Reply  by Damasceno, Albertino et al.
Recently, an echocardiographic approach demonstrated that the
prevalence of rheumatic heart disease in sub-Saharan Africa was
10 higher than previously reported (2). In other words, 9 out of
10 children have only minor infra-clinical rheumatic valve lesions
and would not have been detected by the clinical criteria used in
previous surveys. Secondary prophylaxis measures, based on monthly
penicillin injections in children after a first episode of acute rheumatic
fever and continued until the third decade, have been shown to be
inexpensive and efficient. This therapeutic strategy is best delivered as
part of a register-based control program, providing education and
enabling better clinical follow-up. This approach has been recom-
mended by the World Health Organization and the World Heart
Federation since the 1980s.
Comprehensive echocardiographic screening programs could
also enhance effective prevention strategies for rheumatic heart
disease. Early detection of “subclinical” rheumatic valve disease is
vital, as it presents an opportunity for case detection at a time when
prophylactic penicillin can prevent progression to clinical valve
disease and heart failure in young adult life.
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Reply
We agree with Drs. Marijon and Jouven that the time has come for
the adoption of echocardiographic screening as part of a strategy
for the early detection of rheumatic heart disease in endemic
regions of the world such as Africa, Southeast Asia, and the
Asia-Pacific region. The Pan African Society of Cardiology
(PASCAR) has called for the implementation of the Awareness-
Surveillance-Advocacy-Prevention (A.S.A.P.) Programme for the
prevention of rheumatic fever and rheumatic heart disease in
Africa, which embraces echocardiographic screening as part of an
effort to rid the continent of the scourge of rheumatic heart disease
“in our own lifetime” (1,2).
Although we agree with the overall thrust of the comment by
Drs. Marijon and Jouven, the statement that “rheumatic heart
disease is the most frequent cause of heart failure in this region of
the world” may only apply to children and young adults. A pooling
study of 12 hospital-based case series involving 4,548 patients from
8 countries (Cameroon, Ghana, Kenya, Nigeria, Senegal, South
Africa, Uganda, and Zimbabwe) has shown that hypertension
(23%) is the leading cause of heart failure in sub-Saharan Africa,
followed closely by rheumatic heart disease (22%), and cardiomy-
opathy (20%) (3).
Finally, the natural history of patients with “subclinical” (i.e., no
history of rheumatic fever, no symptoms, no signs, no mitral
stenosis) echocardiographic features suggestive of rheumatic heart
disease that were detected in the study by Marijon et al. (4) is
unknown. Studies are needed to examine the appropriate manage-
ment of these cases with borderline abnormalities that are likely to
be found in large numbers in through echocardiographic screening
for rheumatic heart disease.
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